B. Tas, N. Kalk, P. Cho, M. Lozano-García, G. Rafferty, M. Kelleher, J. Moxham, J. Strang, C. Jolley
{"title":"P85阿片类药物依赖慢性阻塞性肺疾病患者的呼吸抑制","authors":"B. Tas, N. Kalk, P. Cho, M. Lozano-García, G. Rafferty, M. Kelleher, J. Moxham, J. Strang, C. Jolley","doi":"10.1136/thorax-2021-btsabstracts.195","DOIUrl":null,"url":null,"abstract":"P85 Table 1 Presence of respiratory depression criteria in all participants with OUD and their corresponding control groups. Fisher’s exact test was used to test for differences between criteria, both groups showed significant differences. OUD without LD and healthy controls p=0.021, and OUD-LD and LD-controls p=0.0001. participants took OST medication on the day of testing. OUD: Opioid Use Disorder; LD: Lung Disease; SpO2: pulse oximetry; ETCO2: end-tidal CO2; TcCO2: transcutaneous CO2.","PeriodicalId":201678,"journal":{"name":"The real-world care of COPD patients","volume":"78 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"P85 Respiratory depression in opioid dependent chronic obstructive pulmonary disease patients\",\"authors\":\"B. Tas, N. Kalk, P. Cho, M. Lozano-García, G. Rafferty, M. Kelleher, J. Moxham, J. Strang, C. Jolley\",\"doi\":\"10.1136/thorax-2021-btsabstracts.195\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"P85 Table 1 Presence of respiratory depression criteria in all participants with OUD and their corresponding control groups. Fisher’s exact test was used to test for differences between criteria, both groups showed significant differences. OUD without LD and healthy controls p=0.021, and OUD-LD and LD-controls p=0.0001. participants took OST medication on the day of testing. OUD: Opioid Use Disorder; LD: Lung Disease; SpO2: pulse oximetry; ETCO2: end-tidal CO2; TcCO2: transcutaneous CO2.\",\"PeriodicalId\":201678,\"journal\":{\"name\":\"The real-world care of COPD patients\",\"volume\":\"78 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The real-world care of COPD patients\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/thorax-2021-btsabstracts.195\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The real-world care of COPD patients","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/thorax-2021-btsabstracts.195","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
P85 Table 1 Presence of respiratory depression criteria in all participants with OUD and their corresponding control groups. Fisher’s exact test was used to test for differences between criteria, both groups showed significant differences. OUD without LD and healthy controls p=0.021, and OUD-LD and LD-controls p=0.0001. participants took OST medication on the day of testing. OUD: Opioid Use Disorder; LD: Lung Disease; SpO2: pulse oximetry; ETCO2: end-tidal CO2; TcCO2: transcutaneous CO2.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
